Medical Research News

RSS

Cellular automata imaging-based classification of SARS-CoV-2 variants

A new preprint classified and grouped SARS-CoV-2 variants based on their cellular automata imaging images and Hamming distances, to determine viral evolutions.

22 Feb 2022

Study explores the decline in viral load and immune response in COVID-19 patients

Researchers described the changes in viral ribonucleic acid the decline in viral load, and the immune response of SARS-CoV-2-infected patients, in a new preprint study.

22 Feb 2022

SARS-CoV-2 Omicron variant rapidly takes over Delta viral strain in Norwegian households

Researchers compared the secondary attack rates SARS-CoV-2 Omicron and Delta variants of concern in Norwegian households.

22 Feb 2022

One in three students reported better mental health and wellbeing during COVID-19 lockdown

One in three young people say their mental health and wellbeing improved during COVID-19 lockdown measures, with potential contributing factors including feeling less lonely, avoiding bullying and getting more sleep and exercise, according to researchers at the universities of Cambridge and Oxford.

22 Feb 2022

Assessing the transmissibility of SARS-CoV-2 variants of concern

A new study investigated and compared the transmissibility of severe acute respiratory syndrome coronavirus-2 variants of concern.

22 Feb 2022

Severity of SARS-CoV-2 infections with Omicron BA.2 variant relative to the BA.1 variant in South Africa

Researchers estimated the clinical severity of the SARS-CoV-2 Omicron BA.2 sublineage relative to the BA.1 variant in South Africa.

22 Feb 2022

Study offers a new, effective therapeutic option against glioblastoma

A study recently accepted for publication in The Journal of Clinical Investigation describes a new and effective therapy to treat glioblastoma: the concomitant use of ADI-PEG20 together with focal brain radiotherapy.

22 Feb 2022

REGEN-COV antibody combination to prevent COVID-19 severity

A new study assessed the effectiveness of REGEN-COV, a combination of casirivimab and imdevimab monoclonal antibodies, in the prevention of COVID-19 disease severity.

22 Feb 2022

Daily activities linked to lower risk of heart disease in older women

Seniors take note, running or brisk walking is not the only way to reduce the risk of heart disease. Simply being "up and about" performing routine activities, referred to as daily life movement, including housework, gardening, cooking and self-care activities like showering can significantly benefit cardiovascular health.

22 Feb 2022

Study provides a potent biparatopic antibody against all SARS-CoV-2 variants of concern

Researchers demonstrated the potent neutralization of SARS-CoV-2 VOCs, including Omicron by the biparatopic human heavy chain variable domain.

22 Feb 2022

Prevalence of chemosensory loss induced by SARS-CoV-2 Omicron variant in Italy

Researchers conducted a prospective cohort study to determine the prevalence of chemosensory dysfunction in mild to moderate COVID-19 patients in Italy.

22 Feb 2022

SARS-CoV-2 reinfection risk in the population of the Abruzzo Region of Italy

Researchers evaluated the incidences of SARS-CoV-2 reinfections, hospitalizations, and death among the previously infected population of the Abruzzo region in Italy.

22 Feb 2022

Studies continue to prove ivermectin for COVID-19 treatment ineffectual

Researchers from hospitals around Malaysia have been looking into the efficacy of the controversial drug ivermectin as a possible COVID-19 treatment.

22 Feb 2022

Widely utilized SARS-CoV-2 rapid antigen detection tests continue to perform as expected despite Omicron mutations

A recent study evaluated the performance of three at-home COVID-19 rapid antigen tests commonly used in the US against the SARS-CoV-2 Omicron variant.

22 Feb 2022

Lung microbiome alterations and secondary-infections in lethal COVID-19

Researchers examined how an interplay of host and microbial factors weakened immunity leading to secondary infections in COVID-19-infected individuals.

22 Feb 2022

Study suggests anti-SARS-CoV-2 antibodies may persist lifelong post-infection

Researchers attempted to delineate the duration and stability of anti-SARS-CoV-2 antibodies in patients who had recovered from the COVID-19 infection.

22 Feb 2022

SARS CoV-2 in deer from Pennsylvania sampled during fall and winter 2021

Researchers examined whether SARS-CoV-2-infected white-tailed deer could be the new animal reservoir with the potential to spillback new SARS-CoV-2 variants into humans.

22 Feb 2022

Spectrum of autoantibodies linked to autoimmune diseases in patients with different COVID-19 clinical outcomes

A broad evaluation of autoimmune disease-associated autoantibodies that have been observed in COVID-19 patients was performed.

22 Feb 2022

SARS-CoV-2 occurrence compared with other respiratory viruses in children with acute respiratory infections

The current study examined the incidence of COVID-19 in children with ARI relative to other respiratory viruses during the second and third waves.

22 Feb 2022

Time-based sensitivity of COVID-19 serological testing

In a recent study under consideration at Scientific Reports and posted to the Research Square* preprint server, researchers evaluated the impact of time on the sensitivity of four severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serological assays using samples from the coronavirus disease 2019 (COVID-19) staff testing of antibody responses study(Co-Stars) in the United Kingdom (UK).

22 Feb 2022

Medical Research News

Cellular automata imaging-based classification of SARS-CoV-2 variants

Study explores the decline in viral load and immune response in COVID-19 patients

SARS-CoV-2 Omicron variant rapidly takes over Delta viral strain in Norwegian households

One in three students reported better mental health and wellbeing during COVID-19 lockdown

Assessing the transmissibility of SARS-CoV-2 variants of concern

Severity of SARS-CoV-2 infections with Omicron BA.2 variant relative to the BA.1 variant in South Africa

Study offers a new, effective therapeutic option against glioblastoma

REGEN-COV antibody combination to prevent COVID-19 severity

Daily activities linked to lower risk of heart disease in older women

Study provides a potent biparatopic antibody against all SARS-CoV-2 variants of concern

Prevalence of chemosensory loss induced by SARS-CoV-2 Omicron variant in Italy

SARS-CoV-2 reinfection risk in the population of the Abruzzo Region of Italy

Studies continue to prove ivermectin for COVID-19 treatment ineffectual

Widely utilized SARS-CoV-2 rapid antigen detection tests continue to perform as expected despite Omicron mutations

Lung microbiome alterations and secondary-infections in lethal COVID-19

Study suggests anti-SARS-CoV-2 antibodies may persist lifelong post-infection

SARS CoV-2 in deer from Pennsylvania sampled during fall and winter 2021

Spectrum of autoantibodies linked to autoimmune diseases in patients with different COVID-19 clinical outcomes

SARS-CoV-2 occurrence compared with other respiratory viruses in children with acute respiratory infections

Time-based sensitivity of COVID-19 serological testing

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Latest News